论文部分内容阅读
目的评价采用调强适形放射治疗(IMRT)技术再程放疗复发恶性脑胶质瘤患者的生存质量。方法根据EORTC QLQ-C30量表调查25例复发恶性脑胶质瘤患者接受再程常规分割放射治疗的生存质量。结果患者IMRT后的躯体功能、角色功能、认知功能维持在IMRT前的稳定水平(P>0.05),总体健康状况较前好转(P<0.05)。患者IM-RT后的疲倦和疼痛症状维持在IMRT前的水平(P>0.05),恶心/呕吐症状有所减轻(P<0.05)。结论 IMRT再程放疗对复发恶性脑胶质瘤患者安全、有效。
Objective To evaluate the quality of life of recurrent malignant glioma patients treated with IMRT. Methods According to the EORTC QLQ-C30 scale, the quality of life of 25 patients with recurrent malignant glioma undergoing routine routine radiotherapy was investigated. Results After IMRT, the physical function, the function of the body and the cognitive function remained stable before IMRT (P> 0.05), and the general health was better than before (P <0.05). The symptoms of tiredness and pain after IM-RT were maintained at pre-IMRT levels (P> 0.05), and nausea / vomiting symptoms were relieved (P <0.05). Conclusions IMRT reradiation is safe and effective for patients with recurrent malignant glioma.